Nucleus family,

This is the longest I've ever gone without sending a monthly update. For that, I apologize, but because of that, I have a lot of exciting news to share in this update.

Things have been moving quite quickly for us following our launch of Neuly 2.0 (Note: You can check out the official press release here). Since the launch, we've engaged with dozens of organizations and welcomed thousands of new users onto the platform.

And we're just getting started.

The Launch of "The New Neuly"

While it's only been a few weeks, here is a rundown of what's happened since we soft launched Neuly in October:

1. 3,387 active users have joined
2. Over 5,000 have been invited to Neuly by their peers
3. We've received 7 research requests
4. We've recruited 13 students for our education partners
5. Over 20 users have connected with practitioners, retreats, or a recruiting clinical trial.
6. Over 7,000 searches have occurred on the platform.

This is all so exciting for us because this is the data we were looking and hoping for. Our model is to connect these users with the experience or solution they are searching for, and by doing so, partnering with providers that can make a true impact on their lives.

NeulyEDU

When we launched, we highlighted our education directory. After all, we went from having about 90 courses to over 450, and added a great deal of intelligence around the providers and what they are looking for when it comes to recruiting students.

So that's become our model. Build funnels for course providers and assist this industry with the feared bottleneck of not having enough practitioners to administer these medicines.

We've been hard at work finding potential students and forging relationships with all of those companies shown on the infographic above. I'm pleased to say that we have over a dozen partnerships, and as the data above shows, we've seen a decent amount of student interest thus far.

Marketing for Ecosystem Partners

With so many users in the Nucleus ecosystem, we continue to take advantage of our ability to help our partners get in front of a large audience.

In October, we facilitated a very successful webinar about psychedelics education alongside the reMind Business Conference.

Our audience loved the event, and the panelists seemed to enjoy it even more. After having over 500 registrants and dozens of pieces of positive feedback, we figured we'd do many more of these events for other partners in the future.

Psychedelic Invest Updates

If you remember our update from September, there was a lot of talk around the industry about how difficult it has become to maintain organic traffic growth. I'm not going to list the many causes and reasons, but the industry is still feeling the hurt of a drastic drop in category searches and general curiosity surrounding "psychedelics."

It's not all bad, though. For Psychedelic Invest, the website is seeing more subscriptions per week than usual. This means that for those that are visiting the site for the first time, they are more engaged. We'll take quality over quantity any day!

Monetization Strategies

We're currently testing a few more ways to drive revenue for Psychedelic Invest. If you head over to the Psychedelic Invest Index, for example, you'll see a banner ad, which has been performing quite well so far.

Psyrise Updates

Psyrise continues to be a useful tool for the handful of clinics that have embedded it into their practices.

The below analytics dashboard reveals that over $250,000 in lead revenue was driven through the system for our largest clinic client during the month of October.

Nucleus: General Updates

Content Processes/Logs: Our daily content log is firing on all cylinders. It's super cool to see every piece of news documented, understood, and put to work through automated technology: https://airtable.com/appbmgUgX4UbghNJY/shr3oN3DtqOOEVOEJ

Keeping Up with the Content

Below is a complete list of all the content we published in October.

Press Releases: 57

Original Articles and Events:

• California Psychedelic Reform Bill Quickly Approaches the End of the Road
• Building a Supportive Infrastructure for the Emerging Psychedelic Industry
• Roland Griffiths: An Extraordinary Life & Legacy in Psychedelic Research
• The Peyote Predicament: A Controversial Debate in the Psychedelic Industry

Q3 Industry Report:

• Q3 Overview: The State of the Psychedelic Sector

We Launched Season 4 of the Psychedelic Invest Podcast:

• James Gilligan is Leading the Next Wave of Psilocybin – Podcast Episode #35
• Jennifer Chesak Writes About Psilocybin and Women – Podcast Episode #36

November Thus Far

Even though we're already halfway through the month, we're looking forward to summarizing all our success in November for you. We've already landed a few more clients, have continued to garner new users for Neuly, we put on a fantastic event in Miami, and will be publishing an education report.

Oh, and if you'll be in Vegas for the reMind conference, Neuly will have a booth there. So please stop by and say hi.

Until the Next Update

I'll leave you with a picture of how my October ended a few weeks ago. It was on a very fun night of trick or treating with this ridiculous Harry Potter crew.

As always, please reach out to me at [email protected] if you ever have any questions, concerns, or ideas.

Have a great Thanksgiving!